Journal of Hypertension

Journal

Publication Venue For

  • Associations of awake and asleep blood pressure and blood pressure dipping with abnormalities of cardiac structure: The Coronary Artery Risk Development in Young Adults study.  38:102-110. 2020
  • Sex differences in masked hypertension: The Coronary Artery Risk Development in Young Adults study.  37:2380-2388. 2019
  • Clinical characteristics, antihypertensive medication use and blood pressure control among patients with treatment-resistant hypertension: The Survey of PatIents with treatment ResIstant hyperTension study.  37:2216-2224. 2019
  • Prevalence of ambulatory blood pressure phenotypes using the 2017 American College of Cardiology/American Heart Association blood pressure guideline thresholds: Data from the Coronary Artery Risk Development in Young Adults study.  37:1401-1410. 2019
  • Reply.  36:1423-1424. 2018
  • Gender, blood pressure, and cardiovascular and renal outcomes in adults with hypertension fromthe Systolic Blood Pressure InterventionTrial.  36:904-915. 2018
  • What is the most appropriate target SBP in persons with hypertension and diabetes mellitus?.  36:37-40. 2018
  • Should sleep blood pressure be used as a criterion to define white-coat hypertension?.  35:2372-2373. 2017
  • Associations of blood pressure, sunlight, and Vitamin D in community-dwelling adults.  34:1704-1710. 2016
  • OS 24-04 A PILOT STUDY ASSESSING THE FEASIBILITY OF VASCULAR FUNCTION IN LOW SOCIOECONOMIC STATUS PRESCHOOL CHILDREN..  34 Suppl 1:e244. 2016
  • OS 33-02 IN PATIENTS WITH RESISTANT HYPERTENSION INCREASED 24-H URINARY CORTISOL LEVEL PREDICT INCREASED BODY MASS INDEX..  34 Suppl 1:e393. 2016
  • OS 33-02 IN PATIENTS WITH RESISTANT HYPERTENSION INCREASED 24-H URINARY CORTISOL LEVEL PREDICT INCREASED BODY MASS INDEX..  34 Suppl 1 - ISH 2016 Abstract Book:e393. 2016
  • SY 11-3 HYPERTENSION IN WOMEN: MORE DANGEROUS THAN IN MEN?.  34 Suppl 1:e366. 2016
  • SY 11-3 HYPERTENSION IN WOMEN: MORE DANGEROUS THAN IN MEN?.  34 Suppl 1 - ISH 2016 Abstract Book:e366. 2016
  • Is white-coat hypertension associated with increased cardiovascular and mortality risk?.  34:1655-1658. 2016
  • Antihypertensive medications and sexual function in women: Baseline data from the SBP intervention trial (SPRINT).  34:1224-1231. 2016
  • Urinary sodiumexcretion predicts blood pressure response to spironolactone in patients with resistant hypertension independent of aldosterone status.  34:1005-1010. 2016
  • Differences in night-time and daytime ambulatory blood pressure when diurnal periods are defined by self-report, fixed-times, and actigraphy: Improving the Detection of Hypertension study.  34:235-243. 2016
  • Effects of pentoxifylline on inflammatorymarkers and blood pressure: A systematic reviewandmeta-analysis of randomized controlled trials.  34:2318-2329. 2016
  • Are two commonly used self-report questionnaires useful for identifying antihypertensive medication nonadherence?.  33:1108-1113. 2015
  • Differences in cardiovascular disease risk when antihypertensive medication adherence is assessed by pharmacy fill versus self-report: The Cohort Study of Medication Adherence among Older Adults (CoSMO).  33:412-420. 2015
  • Predictors and outcomes of resistant hypertension among patients with coronary artery disease and hypertension.  32:635-643. 2014
  • Age and the effectiveness of anti-hypertensive therapy on improvement in diastolic function.  32:174-180. 2014
  • Reversibility of left ventricular mechanical dysfunction in patients with hypertensive heart disease.  32:2479-2487. 2014
  • The effects of weight loss and salt reduction on visit-to-visit blood pressure variability: Results from a multicenter randomized controlled trial.  32:840-848. 2014
  • The contributions of unhealthy lifestyle factors to apparent resistant hypertension: Findings from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study.  31:370-376. 2013
  • High dietary sodium intake impairs endothelium-dependent dilation in healthy salt-resistant humans.  31:530-536. 2013
  • Predictors of lowering SBP to assigned targets at 12 months in the Secondary Prevention of Small Subcortical Strokes study.  30:1233-1240. 2012
  • Hypertension and orthostatic hypotension in older patients.  30:38-39. 2012
  • Reproducibility of visit-to-visit variability of blood pressure measured as part of routine clinical care.  29:2332-2338. 2011
  • The relationship between renal impairment and left ventricular structure, function, and ventricular-arterial interaction in hypertension.  29:1829-1836. 2011
  • Transforming growth factor-╬▓ inhibits myocardial PPAR╬│ expression in pressure overload-induced cardiac fibrosis and remodeling in mice.  29:1810-1819. 2011
  • Moderate versus intensive treatment of hypertension with amlodipine/valsartan for patients uncontrolled on angiotensin receptor blocker monotherapy.  29:161-170. 2011
  • Pharmacogenetic association of hypertension candidate genes with fasting glucose in the GenHAT Study.  28:2076-2083. 2010
  • Facts and fallacies of blood pressure control in recent trials: implications in the management of patients with hypertension.  27:673-679. 2009
  • Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: The Losartan Intervention for Endpoint reduction in hypertension study.  27:567-574. 2009
  • Factor relationships of metabolic syndrome and echocardiographic phenotypes in the HyperGEN study.  26:1360-1366. 2008
  • Pathogenesis of essential hypertension: Historical paradigms and modern insights.  26:381-391. 2008
  • Aldosterone excess and resistance to 24-h blood pressure control.  25:2131-2137. 2007
  • Glcosamine inhibits inflammatory response to tumor necrosis factor-alpha in vascular smooth muscle cells via augmentation of protein O-GlcNAcylation.  24:179-180. 2006
  • Synergistic protective effects of erythropoietin and olmesartan on ischemic stroke survival and post-stroke memory dysfunctions in the gerbil.  24:2255-2261. 2006
  • Vascular and metabolic effects of candesartan: Insights from therapeutic interventions.  24. 2006
  • Hypertension after experimental cerebral ischemia: Candesartan provides neurovascular protection.  24:535-539. 2006
  • Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in hypertension with left ventricular hypertrophy? A LIFE substudy.  22:1805-1811. 2004
  • Diuretic-induced hyperuricemia does not decrease cardiovascular risk [2] (multiple letters).  22:1415-1419. 2004
  • Diuretic-induced hyperuricemia does not decrease cardiovascular risk..  22:1415-1417. 2004
  • Elevated arterial pressure impairs autoregulation independently of AT 1 receptor activation.  22:811-818. 2004
  • Effect of dietary fiber intake on blood pressure: A randomized, double-blind, placebo-controlled trial.  22:73-80. 2004
  • Comparison of the SCOPE and LIFE results [2] (multiple letters).  21:1772-1773. 2003
  • Comparison of the SCOPE and LIFE results..  21:1772-1773. 2003
  • Prevalence of renal artery stenosis in high-risk veterans referred to cardiac catheterization.  21:1157-1162. 2003
  • Prevalence of renal artery stenosis in high-risk veterans referred to cardiac catheterization..  21:1157-1162. 2003
  • Decreased endothelin binding and [Ca2+]i signaling in microvessels of DOCA-salt hypertensive rats.  20:1799-1805. 2002
  • Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study.  20:1879-1886. 2002
  • Role of weight loss and polyunsaturated fatty acids in improving metabolic fitness in moderately obese, moderately hypertensive subjects.  19:1745-1754. 2001
  • Interaction between lifetime captopril treatment and NaCl-sensitive hypertension in spontaneously hypertensive rats and Wistar-Kyoto rats.  17:983-991. 1999
  • Relationship of diastolic blood pressure with cyclic GMP excretion among young adults (the CARDIA study): Influence of a family history of hypertension.  15:955-962. 1997
  • Relationship of diastolic blood pressure with cyclic GMP excretion among young adults (the CARDIA Study): influence of a family history of hypertension. Coronary Artery Risk Development in Young Adults..  15:955-962. 1997
  • Contribution of the sympathetic nervous system to salt-sensitivity in lifetime captopril-treated spontaneously hypertensive rats.  13:1037-1042. 1995
  • Muscle sympathetic nervous system activity in black and caucasian hypertensive subjects.  12:1291-1296. 1994
  • Air jet noise exposure rapidly increases blood pressure in young borderline hypertensive rats.  9:275-282. 1991
  • Atrial natriuretic peptide inhibits sympathetic outflow in NaCi-sensitive spontaneously hypertensive rats.  9:1177-1185. 1991
  • Dietary ca2+ increases natriuretic and diuretic responses to volume loading in nacl-sensitive spontaneously hypertensive rats.  8:947-951. 1990
  • Dietary ca2+ prevents naci-induced exacerbation of hypertension and increases hypothalamic norepinephrine turnover in spontaneously hypertensive rats.  7:711-719. 1989
  • Hypothalamic microinjection of alpha2-adrenoceptor agonists causes greater sympathoinhibition in spontaneously hypertensive rats on high NaCl diets.  6:805-813. 1988
  • Prediction of response to sodium intervention for blood pressure control.  4. 1986
  • Effect of central administration of MK-422 (the diacid form of enalapril) on the development of hypertension in the spontaneously hypertensive rat.  2:63-66. 1984
  • Effect of dietary change on the return of hypertension after withdrawal of prolonged antihypertensive therapy (DISH).  2:179-181. 1984
  • International Standard Serial Number (issn)

  • 0263-6352
  • Electronic International Standard Serial Number (eissn)

  • 1473-5598